Prednisolone Acetate

Verify with FDA CVM →

23 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
23
Total Reports
7
Deaths Reported
3040.0%
Death Rate

Active Ingredients

Prednisolone Acetate

Administration Routes

OphthalmicUnknownIntraocularTopicalIntramuscularOralSubcutaneousNasal

Species Affected

Dog 15
Cat 8

Most Affected Breeds

Domestic Shorthair 5
Retriever - Labrador 2
Dachshund (unspecified) 2
Crossbred Canine/dog 2
Spitz - German Pomeranian 1
Domestic Longhair 1
Terrier - Yorkshire 1
Maine Coon 1
Poodle (unspecified) 1
Spaniel - King Charles Cavalier 1

Most Reported Reactions

Vomiting 6
Corneal disorder NOS 5
Blepharospasm 4
Other abnormal test result NOS 4
Weight loss 4
Anorexia 3
Death by euthanasia 3
Neutrophilia 3
Diarrhoea 3
Death 3
Corneal ulcer 3
Eye disorder NOS (for photophobia see 'neurological') 2

Outcome Breakdown

Ongoing
6 (26.1%)
Outcome Unknown
6 (26.1%)
Euthanized
4 (17.4%)
Died
3 (13.0%)
Recovered/Normal
3 (13.0%)
Recovered with Sequela
1 (4.3%)

Data Summary

Metric Value
Total adverse event reports 23
Reports involving death 7
Case-fatality rate (reported events) 3040.0%
Distinct species in reports 2
Distinct breeds in reports 16
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Prednisolone Acetate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 23 adverse event reports referencing Prednisolone Acetate, including 7 reports in which the animal died — a 3040.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Prednisolone Acetate. Reported administration routes include Ophthalmic, Unknown, Intraocular, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Prednisolone Acetate reports are Dog (15 reports), Cat (8 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (5), Retriever - Labrador (2), Dachshund (unspecified) (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Prednisolone Acetate are Vomiting (6), Corneal disorder NOS (5), Blepharospasm (4), Other abnormal test result NOS (4). Of the 23 reports with a coded outcome, Ongoing is the leading category at 26.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Prednisolone Acetate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial